Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

1,078 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    CMS Finalizes Risk Adjustment Model In 2024 Rate Announcement For Medicare Advantage And Part D

    On March 31, 2023, the US Centers for Medicare & Medicaid Services issued its Announcement of Calendar Year 2024 Medicare Advantage Capitation Rates and Part C and Part D Payment Policies, otherwise known as the Rate Announcement.
    United KingdomFood, Drugs, Healthcare, Life Sciences
    McDermott Will & Emery
    McDermott Will & Emery
  • Article

    Food & Drink On The International Stage – Food & Drink Exporters Association

    Against a backdrop of painfully rising costs, economic uncertainty and the aftermath of Brexit, it's no wonder that over 50% of UK food & drink companies are now looking abroad...
    United KingdomFood, Drugs, Healthcare, Life Sciences
Kilburn & Strode
Kilburn & Strode
  • Article

    "For Medical Purposes" – A Case For Unblurring The Lines Between Pharma And Nutritional Products

    Food-pharma industry convergence is not a new development. In 2013, a study of the patent citation data of 274 published European patents by 5 EU Medical Nutrition companies revealed the...
    United KingdomFood, Drugs, Healthcare, Life Sciences
    HGF Law
    HGF Law
  • Article

    The Cost Of Unused Medicines In The UK

    April 30th is National Take Back Day in the US. Take back events encourage consumers/patients to return unused medicines that are lying around their homes to pharmacies, so that they can be disposed of properly.
    United KingdomFood, Drugs, Healthcare, Life Sciences
    Deloitte
    Deloitte
  • Article

    The European Parliament And Council Reach Provisional Agreement On The EU "Pharma Package"

    The European Parliament and Council have reached a provisional agreement on the EU "pharma package", introducing significant reforms to pharmaceutical legislation to modernise regulation and enhance access to medicines
    United KingdomFood, Drugs, Healthcare, Life Sciences
    Potter Clarkson LLP
    Potter Clarkson LLP
  • Article

    What Is Healthwashing And What Is A Claim?

    Healthwashing is the term used to describe the act of making a product (most frequently a food or drink) appear healthier than it is by making certain claims.
    United KingdomFood, Drugs, Healthcare, Life Sciences
    Potter Clarkson LLP
    Potter Clarkson LLP
  • Article

    World-First Nitrous Oxide Breathalyser Trial

    Police in England have today announced the trial of what is believed to be the world’s first roadside breathalyser designed specifically to detect nitrous oxide, more commonly known as “laughing gas”. For anyone concerned about drug driving investigations, this represents a significant development and could mark a turning point in how these cases are investigated and prosecuted.
    United KingdomFood, Drugs, Healthcare, Life Sciences
    Olliers Solicitors
    Olliers Solicitors
  • Article

    Tropical Animal Diseases Such As BTV Pose A Growing Risk To Food Production

    The article discusses the growing risk of vector-borne diseases like Bluetongue Virus due to climate change, highlighting impacts on livestock, food production, and insurance. It emphasizes the need for proactive mitigation strategies and tailored insurance solutions.
    United KingdomInsurance
    WTW
    WTW
  • Article

    AI And Data Analytics In Food Tech

    The integration of artificial intelligence (AI) and data analytics in food technology may lead to new innovations. From personalized nutrition to smart packaging solutions...
    United KingdomIntellectual Property
    Boult Wade Tennant LLP
    Boult Wade Tennant LLP
  • Article

    IP Ingredients, Part 11: Exploring Colours In The Food & Drink Sector – A Patent Perspective

    As the saying goes, "We eat first with our eyes". The visual appearance, especially the colour, of a food or beverage product is one of the first things...
    United KingdomIntellectual Property
    HGF Law
    HGF Law
  • Article

    Reading The Tea Leaves: The ASA And Intellectual Property Rights

    Jonny Mayner reviews two Advertising Standards Authority Decisions from 2018 in which the regulator has taken a view on the validity or subsistence of intellectual property rights. Is the ASA overstepping its bounds?
    United KingdomIntellectual Property
    Freeths LLP
    Freeths LLP
  • Article

    T 0295/22: EPO Technical Board Of Appeal Relies On "Bonus Effect" Case Law To Find Amgen's Patent To Orally Administered Apremilast Lacking In Inventive Step

    This case concerned Amgen's European patent no. 2962690 for apremilast, a drug sold under the brand name Otezla®, licensed for the treatment of e.g., psoriasis and psoriatic arthritis.
    United KingdomIntellectual Property
    HGF Law
    HGF Law
  • Article

    The Importance Of Trade Marks In The Food And Drink Industry…from 1875 To Present Day

    Perhaps not the ideal way to see in the new year, but rumour has it that one employee of Bass Brewery spent the cold New Year's Eve of 1875 queuing outside the then Patent Office.
    United KingdomIntellectual Property
    Dehns
    Dehns
  • Article

    The Rising Tide Of Seaweed Patents

    Seaweed is emerging as a versatile innovation driver across various industries. With over 15,000 patents since 2015, it is revolutionizing sectors from food and health to biofuels, bioplastics, and environmental solutions, highlighting its sustainable potential.
    United KingdomIntellectual Property
    Potter Clarkson LLP
    Potter Clarkson LLP
  • Article

    È Ancora Vigente E Viene Applicato L'art. 62?

    Com’è noto, l’art. 62 del Decreto Liberalizzazioni (D.L. 1/2012) detta una disciplina speciale in tema di cessione dei prodotti agricoli ed agroalimentari che sinteticamente
    United KingdomAntitrust/Competition Law
    Withers LLP
    Withers LLP
  • Article

    Pharmacy brief - March 2013

    The CR Pharmacy Team’s annual conference will be held on 30 April 2013 at our London office.
    United KingdomFood, Drugs, Healthcare, Life Sciences
    Charles Russell Speechlys LLP
    Charles Russell Speechlys LLP
  • Article

    Clinical Trial Proposals As Prior Art

    Clinical trial proposals, often published, may be cited as prior art against patent applications for medical products. Recent case law indicates that while such proposals rarely destroy novelty, they can challenge inventive step, depending on specific case details and expected outcomes.
    United KingdomIntellectual Property
    Marks & Clerk
    Marks & Clerk
  • Article

    European Parliament Backs Reforms To The EU Regulatory Framework For Medicinal Products

    Members of the European Parliament (MEPs) have voted overwhelmingly in favour of the pharmaceutical reform package following a debate on 10 April.
    European UnionFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    Reform Of The Veterinary Medicines Regulations 2013 Takes Shape For GB

    The Veterinary Medicines Directorate (VMD) held a consultation last year on the review of the Veterinary Medicines Regulations 2013 with input from businesses involved in the manufacture, distribution and dispensation of veterinary medicinal products.
    European UnionFood, Drugs, Healthcare, Life Sciences
    Osborne Clarke LLP
    Osborne Clarke LLP
  • Article

    Why Food Security And Sustainable Agriculture Must Go Hand In Hand

    According to the latest estimates, the world's population is predicted to grow to 9.7 billion in 2050 and peak at nearly 10.4 billion by the mid-2080s.
    GlobalFood, Drugs, Healthcare, Life Sciences
    Withers LLP
    Withers LLP
  • Showing 741–760 of 1078 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics